Skip to content

DASH-Sodium Trial in Adolescents

DASH-Sodium Trial in Adolescents

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02993458
Acronym
CampDASH
Enrollment
79
Registered
2016-12-15
Start date
2016-10-31
Completion date
2017-10-18
Last updated
2017-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Blood High Pressure

Keywords

dietary patterns, blood pressure, adolescents, dietary sodium

Brief summary

The Camp DASH study trial will compare the effect of two dietary patterns and two levels of sodium intake on blood pressure and blood lipids in adolescents in the upper third of distribution for blood pressure. The two dietary patterns are based on the Dietary Approaches to Stop Hypertension (DASH) trial in adults.

Detailed description

The Camp DASH study is a controlled trial. the aim of which is to compare the effect of two dietary patterns and two levels of sodium intake on blood pressure and blood lipids in adolescents in the upper third of distribution for blood pressure. The study also assesses whether influences on blood pressure and blood lipids of dietary interventions vary according to sex, race/ethnic groups, baseline levels, and other personal characteristics. The proposed dietary interventions of DASH dietary patterns and sodium reduction have been shown to be effective in lowering blood pressure in adults. The two dietary patterns are based on the Dietary Approaches to Stop Hypertension (DASH) trial in adults. They are a Usual diet typical of what many American adolescents eat, and a DASH-type diet. The DASH diet is rich in fruits, vegetables, and low-fat dairy foods and low in saturated fat and total fat compared to the Usual diet. The two sodium levels are High reflecting current US consumption and Low reflecting current recommended intake levels. Weight will be held constant by adjusting energy intake. The study participants will live in a residence hall on the Purdue campus where all food and beverages will be provided, and meals and snacks will be supervised.

Interventions

OTHERDASH diet

DASH style diet rich in fruits, vegetables, and low-fat dairy foods and low in saturated fat and total fat

OTHERLow Na diet

Sodium intake of 1500 mg/d (65 mmol, or 0.75 mg/Kcal/d), representing the Adequate Intake recommended by the Institute of Medicine.

OTHERHigh Na diet

Sodium intake of 3500 mg/d (152 mmol, or 1.73 mg/Kcal/d, representing the highest sodium intake used for adults in the DASH Sodium trial.

The usual diet will include foods that provide the majority of energy for adolescents in the U.S., i.e. grain based desserts, pizza, sugary drinks,pasta, chicken, and chicken mixed dishes.

Sponsors

Centers for Disease Control and Prevention
CollaboratorFED
Johns Hopkins University
CollaboratorOTHER
Indiana University School of Medicine
CollaboratorOTHER
University of California, San Diego
CollaboratorOTHER
National Heart, Lung, and Blood Institute (NHLBI)
CollaboratorNIH
Purdue University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
PREVENTION
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
11 Years to 15 Years
Healthy volunteers
Yes

Inclusion criteria

* White, black, Hispanic, and Asian * SBP in the upper one-third of the distribution for their given sex, age, and height

Exclusion criteria

* Pre-existing lipid disorders, abnormal liver or kidney function * Taking medications that alter mineral absorption or metabolism, affect blood pressure or lipids * If subjects are taking dietary supplements and refuse to discontinue them 2 months prior to the study. * Taking non-prescription illegal drugs, smoke, or drink alcohol * Pregnancy * Carry an epi pen for food-related allergies

Design outcomes

Primary

MeasureTime frameDescription
Mean systolic blood pressure (SBP)End of 25 day feeding interventionThe primary outcome is mean SBP at the end of each intervention feeding period. Mean end of intervention SBP is the average of daily readings during days 19-25 of each intervention feeding period. Blood pressure will also be measured periodically at baseline and throughout the study.
Non-HDL Cholesterol (HDLC)End of 25 day feeding interventionFasting blood samples for lipids and other variables will be drawn at the beginning and end of each feeding period

Secondary

MeasureTime frameDescription
HDL-cholesterolEnd of 25 day feeding interventionFasting blood samples for lipids and other variables will be drawn at the beginning and end of each feeding period
LDL-cholesterolEnd of 25 day feeding interventionFasting blood samples for lipids and other variables will be drawn at the beginning and end of each feeding period
Cholesterol:HDLC ratioEnd of 25 day feeding interventionFasting blood samples for lipids and other variables will be drawn at the beginning and end of each feeding period.
TriglyceridesEnd of 25 day feeding interventionFasting blood samples for lipids and other variables will be drawn at the beginning and end of each feeding period
Diastolic blood pressure (DBP)End of 25 day feeding interventionThe secondary outcome is mean DBP at the end of each intervention feeding period. Mean end of intervention DBP is the average of daily readings during days 19-25 of each intervention feeding period. Blood pressure will also be measured periodically at baseline and throughout the study..
Regulators of sodium metabolismEnd of 25 day feeding interventionRegulators of sodium homeostasis (renin, aldosterone, angiotensin) will be measured at the beginning and end of the feeding period
Augmentation indexEnd of 25 day feeding interventionPulse wave analysis (At Cor Medical) will be used to measure changes in augmentation index (AI) with intervention to index central blood pressure.
VasoreactivityEnd of 25 day feeding interventionSkin flow motion (laser-doppler flowmetry) to measure diet-induced changes in vaso-reactivity will provide mechanistic information on microvascular control.
Urinary mineral excretionEnd of 25 day feeding interventionTwo 24-hr urine samples at the end of the feeding periods will be analyzed for sodium, potassium, magnesium, and calcium..
Total cholesterolEnd of 25 day feeding interventionFasting blood samples for lipids and other variables will be drawn at the beginning and end of each feeding period.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026